You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trk Fusions

Showing 1 - 25 of 153
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial (TL118 Capsule)

Not yet recruiting
  • Solid Tumor
  • TL118 Capsule
  • (no location specified)
Aug 18, 2023

Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

Recruiting
  • Thyroid Cancer
  • NTRK fusion assessment
  • Roma, Italy
    Regina Elena National Cancer Institute
Mar 31, 2023

A Retro-/Prospective, Non-interventional, Cohort Study in Adult

Active, not recruiting
  • Solid Tumor, Adult
  • +2 more
    • Amiens, France
    • +3 more
    Jul 22, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

    Recruiting
    • Solid Tumors
    • CNS Tumors
    • Orange, California
    • +38 more
    Aug 24, 2022

    CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)

    Active, not recruiting
    • Central Nervous System Neoplasm
    • +4 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +81 more
    Jan 24, 2023

    Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • +3 more
    • Oral repotrectinib (TPX-0005)
    • Los Angeles, California
    • +27 more
    Aug 9, 2022

    NTRK Family Gene Mutation Trial in Germany

    Recruiting
    • NTRK Family Gene Mutation
      • Berlin, Germany
      • +22 more
      Jan 18, 2023

      Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

      Recruiting
      • Soft Tissue Sarcoma
      • +2 more
      • Blood and tumor samples
      • Clermont-Ferrand, France
      • +9 more
      Dec 8, 2021

      Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

      Recruiting
      • Solid Tumors Harboring NTRK Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Los Angeles, California
      • +50 more
      Jan 29, 2023

      Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))

      Recruiting
      • Solid Tumors Harboring NTRK Fusion
      • BAY2757556 (Larotrectinib, Vitrakvi)
      • Palo Alto, California
      • +158 more
      Aug 8, 2022

      Thyroid Carcinoma

      Recruiting
      • Differentiated Thyroid Carcinoma
      • Medullary Thyroid Carcinoma
      • Immunohistochemistry (IHC)
      • +2 more
      • L'Hospitalet De Llobregat, Barcelona, Spain
      • +11 more
      Mar 22, 2022

      NTRK Gene Fusion - Positive Advanced or Recurrent Solid

      Recruiting
      • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Multiple Locations, Japan
        Many locations
      Jan 20, 2023

      Solid Tumors Trial (afatinib)

      No longer available
      • Solid Tumors
      • (no location specified)
      Nov 7, 2022

      NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • +3 more
      • Sydney, New South Wales, Australia
        GenesisCare North Shore
      Jun 16, 2023

      Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

      Not yet recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • TRK-950
      • +2 more
      • Chuo Ku, Japan
        Osaka International Cancer Institute
      Sep 14, 2023

      Called VICTORIA to Learn More About How Well Larotrectinib Works

      Active, not recruiting
      • Solid Tumors Harboring NTRK Fusion
      • Larotrectinib(Vitrakvi, BAY2757556)
      • Data on other treatments
      • Whippany, New Jersey
        Bayer
      Aug 22, 2022

      Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))

      Completed
      • Solid Tumors Harboring NTRK Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Aurora, Colorado
      • +7 more
      May 11, 2021

      Topcon Tonometers CT-800 and TRK-2P and Haag-Streit Goldmann

      Completed
      • Intraocular Pressure
      • Topcon CT-800
      • Topcon TRK-2P
      • Andover, Massachusetts
        Andover Eye Associates
      Jun 6, 2022

      Solid Tumor Trial in Chuo Ku (TRK-950)

      Recruiting
      • Solid Tumor
      • TRK-950
      • Chuo Ku, Tokyo, Japan
        National Cancer Center Hospital
      Jul 6, 2022

      Chemo-induced Peripheral Neuropathy Trial (TRK-750/Placebo, Placebo/TRK-750)

      Withdrawn
      • Chemotherapy-induced Peripheral Neuropathy
      • TRK-750/Placebo
      • Placebo/TRK-750
      • (no location specified)
      Feb 27, 2022

      Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

      Not yet recruiting
      • Advanced Cholangiocarcinoma
      • +2 more
      • (no location specified)
      Feb 3, 2023

      Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision

      Completed
      • Corneal Thickness
      • SP-1P
      • Tokyo, Japan
        Samoncho Clinic
      Jul 19, 2022

      Spine Fusion, Spine Tumor, Spinal Stenosis Trial in San Francisco (Ketamine)

      Not yet recruiting
      • Spine Fusion
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Nov 14, 2023

      Mesothelioma Trial in Worldwide (IAG933)

      Recruiting
      • Mesothelioma
      • Chicago, Illinois
      • +12 more
      Nov 17, 2022